SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Ahmed Solomon, Linda Tsang, Angela J. Woodiwiss, Aletta M. E. Millen, Gavin R. Norton, Patrick H. Dessein, Cardiovascular Disease Risk amongst African Black Patients with Rheumatoid Arthritis: The Need for Population Specific Stratification, BioMed Research International, 2014, 2014, 1

    CrossRef

  2. 2
    Daniel H. Solomon, Chris Tonner, Bing Lu, Seoyoung C. Kim, John Z. Ayanian, M. Alan Brookhart, Jeffrey N. Katz, Ed Yelin, Predictors of Stopping and Starting Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis, Arthritis Care & Research, 2014, 66, 8
  3. 3
    Jinoos Yazdany, Chris Tonner, Gabriela Schmajuk, Grace A. Lin, Amal N. Trivedi, Receipt of Glucocorticoid Monotherapy Among Medicare Beneficiaries With Rheumatoid Arthritis, Arthritis Care & Research, 2014, 66, 10
  4. 4
    Jean-Pascal Roussy, Louis Bessette, Elham Rahme, Sasha Bernatsky, Jean Légaré, Jean Lachaine, Rheumatoid arthritis pharmacotherapy and predictors of disease-modifying anti-rheumatic drug initiation in the early years of biologic use in Quebec, Canada, Rheumatology International, 2014, 34, 1, 75

    CrossRef

  5. 5
    Edward Yelin, Chris Tonner, Seoyoung C. Kim, Jeffrey N. Katz, John Z. Ayanian, M. Alan Brookhart, Daniel H. Solomon, Sociodemographic, Disease, Health System, and Contextual Factors Affecting the Initiation of Biologic Agents in Rheumatoid Arthritis: A Longitudinal Study, Arthritis Care & Research, 2014, 66, 7
  6. 6
    Omar-Javier Calixto, Juan-Manuel Anaya, Socioeconomic status. The relationship with health and autoimmune diseases, Autoimmunity Reviews, 2014, 13, 6, 641

    CrossRef

  7. 7
    Candace H. Feldman, LeRoi S. Hicks, Tabatha L. Norton, Elmer Freeman, Daniel H. Solomon, Assessing the Need for Improved Access to Rheumatology Care, Journal of Clinical Rheumatology, 2013, 19, 7, 361

    CrossRef

  8. 8
    Seoyoung C. Kim, Ed Yelin, Chris Tonner, Daniel H. Solomon, Changes in Use of Disease-Modifying Antirheumatic Drugs for Rheumatoid Arthritis in the United States During 1983–2009, Arthritis Care & Research, 2013, 65, 9
  9. 9
    Candace H. Feldman, Linda T. Hiraki, Jun Liu, Michael A. Fischer, Daniel H. Solomon, Graciela S. Alarcón, Wolfgang C. Winkelmayer, Karen H. Costenbader, Epidemiology and sociodemographics of systemic lupus erythematosus and lupus nephritis among US adults with Medicaid coverage, 2000–2004, Arthritis & Rheumatism, 2013, 65, 3
  10. 10
    Gabriela Schmajuk, Daniel H. Solomon, Jinoos Yazdany, Patterns of Disease-Modifying Antirheumatic Drug Use in Rheumatoid Arthritis Patients After 2002: A Systematic Review, Arthritis Care & Research, 2013, 65, 12
  11. 11
    Jeffrey R. Curtis, Pradeep Sharma, Tarun Arora, Aseem Bharat, Itara Barnes, Michael A. Morrisey, Meredith Kilgore, Kenneth G. Saag, Nicole C. Wright, Huifen G. Yun, Elizabeth Delzell, Physicians' explanations for apparent gaps in the quality of rheumatology care: Results from the US Medicare Physician Quality Reporting System, Arthritis Care & Research, 2013, 65, 2
  12. 12
    Kirk K Lin, Justin L Sewell, The Effects of Race and Socioeconomic Status on Immunomodulator and Anti-Tumor Necrosis Factor Use among Ambulatory Patients With Inflammatory Bowel Disease in the United States, The American Journal of Gastroenterology, 2013, 108, 12, 1824

    CrossRef

  13. 13
    Jie Zhang, Fenglong Xie, Elizabeth Delzell, Lang Chen, Meredith L. Kilgore, Huifeng Yun, Kenneth G. Saag, James D. Lewis, Jeffrey R. Curtis, Trends in the Use of Biologic Agents Among Rheumatoid Arthritis Patients Enrolled in the US Medicare Program, Arthritis Care & Research, 2013, 65, 11